RBC says it has partnered with Cohere Inc. to develop generative artificial intelligence products for the financial industry.

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

(AI). AI technologies such as machine learning, computer vision, natural language processing and reinforcement learning ...

The US FDA has introduced voluntary guidelines on the level of lead content in processed baby foods sold in the country.

The Food and Drug Administration issued draft guidance Jan. 6 on marketing submissions and lifecycle management for ...

Zepp Clarity launched its “Try Before You Buy” program at CES 2025 to enhance hearing aid adoption among older adults facing hearing loss. The program allows hands-on experience with advanced models ...

Critics, however, say the move is too little, too late. Other FDA and pharma news is on AI-enabled medical devices, smaller PBMs, and more.

The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and ...

The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...

The US Food and Drug Administration (FDA) issued a draft guidance to provide recommendations on the use of artificial ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...